Literature DB >> 12956923

Pitfalls in the diagnosis and management of laryngeal chondrosarcoma.

J P Windfuhr1.   

Abstract

Chondrosarcomas of the larynx (CS) are uncommon and predominantly affect the cricoid cartilage. In the larynx they have a distinctive biological behaviour and require individual treatment. A retrospective study was made on three cases of CS, all presenting with compromise of the upper respiratory tract. The medical history varied from several weeks to six years. Correct diagnosis required open resection of the lesion in all cases. Due to intra-operative findings, all patients underwent total laryngectomy. CS grow slowly and are therefore frequently diagnosed late in the course of the disease. A subglottic bulging of the mucosa should indicate high-resolution-computed-tomography of the larynx to exclude affection of the laryngeal framework. Correct diagnosis of laryngeal cartilaginous tumours requires a complete examination of the entirely resected tumour. Only extended and de-differentiated CS indicate further radical surgery, the remainder call for conservative surgical management.

Entities:  

Mesh:

Year:  2003        PMID: 12956923     DOI: 10.1258/002221503768200020

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Well and intermediate differentiated laryngeal chondrosarcoma: toward conservative surgery?

Authors:  Valerio Damiani; Erika Crosetti; Giuseppe Rizzotto; Angelo Camaioni; Giovanni Succo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-23       Impact factor: 2.503

Review 2.  Recurrent chondrosarcoma of the larynx: A case report and literature review.

Authors:  Hong-Wei Zhou; Jing Wang; Yang Liu; Hui-Mao Zhang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  Laryngeal Chondrosarcoma: an Exceptional Localisation of a not Unfrequent Bone Tumor.

Authors:  Mieke Moerman; Bernard Kreps; Ramses Forsyth
Journal:  Sarcoma       Date:  2009-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.